Karl Reyes, MPP

Karl is a seasoned professional with over 6 years of experience in advisory services, specializing in healthcare policy. His expertise lies in navigating the intricate landscape of healthcare regulations and delivering strategic insights to drive positive outcomes.

Previously serving as an advisory professional at KPMG's Health and Government Solutions team, Karl played a pivotal role in conducting audit-related services under the Health and Human Services, Risk Adjustment Data Validation (HHS-RADV) program. His meticulous attention to detail and comprehensive understanding of healthcare policies ensured compliance and accuracy in critical audit processes.

Karl's knowledge extends beyond the HHS-RADV program, encompassing a deep understanding of FDA-related policies that shape the biotech and pharmaceutical industry. With expertise in policies such as the Prescription Drug User Fee Act (PDUFA), Biosimilar User Fee Amendments (BsUFA), Generic Drug User Fee Amendments (GDUFA), and Medical Device User Fee Amendments (MDUFA), Karl has successfully assisted organizations in navigating the complex regulatory frameworks associated with these initiatives.

In addition to his specialized knowledge, Karl possesses a strong grasp of various other healthcare policies, including the 21st Century Cures Act, the No Surprises Act, and the Orphan Drug Act. This breadth of policy understanding allows him to provide comprehensive guidance to clients and contribute to the advancement of healthcare practices.

Outside of his professional endeavors, Karl resides in Alexandria, VA, with his loyal companion Haku, his dog. He embraces an active lifestyle, and frequently engages in exercises at the gym. Karl also enjoys the game of chess and hopes to one day compete in a FIDE sponsored tournament.

With a passion for healthcare policy, a dedication to excellence, and a diverse set of interests, Karl remains committed to making a meaningful impact in the industry and assisting organizations in navigating the ever-evolving healthcare landscape.